Log in to save to my catalogue

Cannabinoids, Blood–Brain Barrier, and Brain Disposition

Cannabinoids, Blood–Brain Barrier, and Brain Disposition

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_65993b21e1284f27b3feb1705c58f21d

Cannabinoids, Blood–Brain Barrier, and Brain Disposition

About this item

Full title

Cannabinoids, Blood–Brain Barrier, and Brain Disposition

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceutics, 2020-03, Vol.12 (3), p.265

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Potential therapeutic actions of the cannabinoids delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are based on their activity as analgesics, anti-emetics, anti-inflammatory agents, anti-seizure compounds. THC and CBD lipophilicity and their neurological actions makes them candidates as new medicinal approaches to treat central nervous syst...

Alternative Titles

Full title

Cannabinoids, Blood–Brain Barrier, and Brain Disposition

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_65993b21e1284f27b3feb1705c58f21d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_65993b21e1284f27b3feb1705c58f21d

Other Identifiers

ISSN

1999-4923

E-ISSN

1999-4923

DOI

10.3390/pharmaceutics12030265

How to access this item